Sort
261,768 grants matching “gene therapy”
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$968,937William C Hahn · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Immunology of Acute and Chronic Viral Hepatitis
$968,816Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Homology-directed repair: BRCA2 and RAD51 paralogs
$968,795Maria Jasin · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Program to promote lung regeneration and block fibrosis
$968,766Harold A Chapman · University Of California, San Francisco · R35 · FY2023 · HL
Program to promote lung regeneration and block fibrosis
$968,766Harold A Chapman · University Of California, San Francisco · R35 · FY2022 · HL
A New Drug Therapy for Advanced Heart Failure
$968,717Terence Kelly · Cornovus Pharmaceuticals, Inc. · R44 · FY2020 · HL
Studies in pig-to-primate cardiac xenotransplantation
$968,459Christopher G.a. Mc Gregor · Mayo Clinic Rochester · U01 · FY2013 · AI
Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates
$968,416Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2021 · AI
Gene Regulation as a Foundation for Autoimmune Disease Prevention
$968,284Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · U01 · FY2020 · AI
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$968,250Claire F Verschraegen · Ohio State University · UG1 · FY2023 · CA
CANCER AND INFLAMMATION GENETICS
$968,200Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$968,200Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Cannabinoid CB1 and CB2 receptors and drug abuse
$968,160Zheng-Xiong Xi · National Institute On Drug Abuse · ZIG · FY2022 · DA
Human Apyrase Therapy for Acute Ischemic Stroke
$968,157Ridong Chen · Apt Therapeutics, Inc. · SB1 · FY2016 · NS
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$967,866Andrea Califano · Columbia University Health Sciences · U01 · FY2025 · CA
Harnessing the Host Response to Leptosporisis for Diagnosis and Prognosis
$967,771Megan Elizabeth Reller · University Of California Los Angeles · P01 · FY2023 · AI
Biomarker and Phenotypic Risk Factors for Breast Cancer Lymphedema
$967,755Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2015 · CA
A Safety and Efficacy study of AAV2-hAADC for AADC deficiency
$967,730Krystof S Bankiewicz · University Of California, San Francisco · R01 · FY2016 · NS
Cadaveric Donor Lung and Bone Marrow Transplantation in Immunodeficiency Diseases
$967,370Paul Szabolcs · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI
NRSA Training Core
$967,365Emma Anne Meagher · University Of Pennsylvania · TL1 · FY2025 · TR
Hormone Receptors and Genes Regulating Gonadal and mammary function
$967,347Maria Dufau · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
$967,232Joerg Herrmann · Mayo Clinic Rochester · R01 · FY2020 · CA
Identifying and targeting collateral lethal vulnerabilities in cancers
$967,038Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Identifying and targeting collateral lethal vulnerabilities in cancers
$967,038Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Hybrid Molecules Designed to Enhance Antibiotic Activity
$967,036George E Wright · Glsynthesis, Inc. · R44 · FY2008 · AI